Diabetic macular oedema (DMO) is the major cause of visual impairment in people with
diabetes. Optical coherence tomography (OCT) is now the most widely used modality to …

Objective To evaluate short-term markers of outcome in diabetic macular edema (DME).
Methods Prospective interventional case series included 122 eyes of 122 patients with …

Objective To evaluate the changes in retinal capillary plexus and the choriocapillaris after a
single intravitreal injection of bevacizumab in eyes with diabetic macular edema using …

Increasing evidence points to inflammation as a key factor in the pathogenesis of diabetic
retinopathy (DR). Choroidal changes in diabetes have been reported and several attempts …

Purpose To evaluate the effect of intravitreal injection of ranibizumab (IVR) on subfoveal
choroidal thickness (SFCT) and its relationship with central macular thickness (CMT) and …

We evaluated the effect of intravitreal bevacizumab injection (IVB) on choroidal thickness,
and studied its association with the therapeutic response in chronic central serous …

Increasing evidence points to inflammation as a key factor in the pathogenesis of diabetic
retinopathy (DR). Choroidal inflammatory changes in diabetes have been reported and in …

Purpose. To access the choroidal structural changes of posterior subtenon triamcinolone
acetonide (PSTA) injection in eyes with refractory diabetic macular edema (DME). Methods …

Objective: This study aimed to analyze the variation in subfoveal choroidal thickness (SFCT)
and its relationship with the variation in central macular thickness (CME) in response to …

Purpose. The aim of this study was to assess the effect of intravitreal injections (IVI) of
ranibizumab and aflibercept on the choroidal thickness (CT) in patients with treatment‐naive …